Company Overview and News

1
Shares rise as Fletcher jumps on Wesfarmers report

2018-04-13 nzherald.co.nz
New Zealand's benchmark S&P/NZX 50 Index rose, with much of the gain driven by Fletcher Building shares, which lifted on a report Australia's Wesfarmers has taken a small stake. Mercury NZ led decliners and A2 Milk fell on concerns it could be hurt by rivalry in sales of dairy products with the A2 protein variant.
Upvote Downvote

 
MARKET WRAP: NZ shares up slightly, Orion down again

2018-04-10 nbr.co.nz
New Zealand shares stayed just above water today, with wins from Pushpay and IkeGPS overcoming further losses for Orion Health.
Upvote Downvote

 
MARKET CLOSE: NZ shares hit record amidst rebalancing, Comvita and Sky TV gain while Pushpay, A2 drop

2018-03-16 nbr.co.nz
New Zealand shares rose in heavy turnover amidst index rebalancing, with Comvita and Sky Network Television gaining while Pushpay and A2 Milk Co dropped.
Upvote Downvote

 
NZ shares hit record amidst rebalancing

2018-03-16 nzherald.co.nz
New Zealand shares rose in heavy turnover amidst index rebalancing, with Comvita and Sky Network Television gaining while Pushpay and A2 Milk Co dropped.
Upvote Downvote

 
MARKET CLOSE: NZ shares mixed; Sky TV, Fletcher gain

2018-03-15 nbr.co.nz
(BusinessDesk) - New Zealand shares were mixed, with Fletcher Building and Sky Network Television rebounding after recent weakness and companies including Spark New Zealand and Ebos Group shedding their rights to dividends.
Upvote Downvote

 
NZ shares mixed; Sky TV, Fletcher gain

2018-03-15 nzherald.co.nz
New Zealand shares were mixed, with Fletcher Building and Sky Network Television rebounding after recent selling and companies including Spark New Zealand and Ebos Group shedding their rights to dividends.
Upvote Downvote

 
A2 Milk leads sharemarket higher

2018-03-12 nzherald.co.nz
New Zealand shares gained, led higher by A2 Milk Co on index inclusion speculation, with Pushpay and Kathmandu Holdings up.
Upvote Downvote

 
MARKET CLOSE: NZ shares gain

2018-03-12 nbr.co.nz
(BusinessDesk) - New Zealand shares gained, led higher by A2 Milk Co on index inclusion speculation, with Pushpay and Kathmandu Holdings up.
Upvote Downvote

 
MARKET CLOSE: NZ shares rise; Metro Glass rebounds ahead of index exit, Comvita falls

2018-03-09 nbr.co.nz
New Zealand shares rose, led higher by a rebounding Metro Performance Glass. Spark New Zealand gained while Comvita fell.
Upvote Downvote

 
NZ shares rise; Spark gains

2018-03-09 nzherald.co.nz
New Zealand shares rose, led higher by a rebounding Metro Performance Glass. Spark New Zealand gained while Comvita fell.
Upvote Downvote

 
Vero sells Tower stake to US private equity Bain Capital for $7.5 million loss

2018-03-08 nzherald.co.nz
Suncorp Group's Vero Insurance has sold its cornerstone stake in rival insurer Tower to US private equity firm Bain Capital for $53.9 million, registering a $7.5m loss in the process.
Upvote Downvote

 
NZ shares fall; MetroGlass sinks to record low

2018-03-07 nzherald.co.nz
New Zealand shares fell as Metro Performance Glass sank to a record low on speculation it may drop out of the S&P/NZX 50 Index. Fisher & Paykel Healthcare, Fletcher Building and a2 Milk were among decliners while Kathmandu and Z Energy rose.
Upvote Downvote

 
MARKET CLOSE: NZ shares join global rally as trade fears ease; Chorus, Mainfreight rise

2018-03-06 nbr.co.nz
New Zealand shares rose as fears eased over US President Donald Trump's new tariffs on metals, renewing demand for equities across the world. Chorus and Mainfreight gained, while Metro Performance Glass fell, matching its record low.
Upvote Downvote

 
NZ shares join global rally as trade fears ease

2018-03-06 nzherald.co.nz
New Zealand shares rose as fears eased over US President Donald Trump's new tariffs on metals, renewing demand for equities across the world. Chorus and Mainfreight gained, while Metro Performance Glass fell, matching its record low.
Upvote Downvote

 
NZ shares follow Asian markets lower

2018-03-01 nzherald.co.nz
New Zealand shares joined a regionwide sell-off with Asian equity markets following Wall Street lower as global investors second-guess the outlook for US interest rates, and as local analysts absorb a "pretty good" earnings season. Sky Network Television fell for a second day.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...